the laboratory dedicated to cognitive health
The SeaMind LabCom has been selected by the French National Research Agency (ANR)!
What is a LabCom ?
It's a shared laboratory bringing together a public research laboratory (NutriNeuro) and a company (Abyss Ingredients), allowing them to work together on a shared research and innovation roadmap.
Since its creation in 2013, this program LabCom allowed the ANR to support 250 partnerships in all scientifical and technological fields.
The aim of
SeaMind ?
To develop innovative, and scientifically proven marine ingredients adapted to the food supplement market to prevent cognitive disorders throughout life.
Why is it important?
Cognitive health is a major public health issue for our society.
Cognitive disorders, i.e memory and mood disorders,
can have a wide-ranging impact, particularly on :
Quality of life
Risk of developing neurodegenerative diseases
Anxiety disorders
Cognitive disorders represent a considerable cost to society. SeaMind will therefore be targeting the most vulnerable populations at critical periods in life to preserve their memory capital for successful ageing.
A proven collaboration
.jpg)
NutriNeuro Laboratory's scientific expertise
Created in 2011 under the supervision of the University of Bordeaux and INRAE, NutriNeuro ‘Nutrition and Integrative Neurobiology’ is a research unit with 80 clinicians, researchers and students in Neuroscience and Nutrition.
The research carried out focuses on the relationship between nutrition and the brain, with the aim of defining optimal nutrition in humans to prevent the development of neurodegenerative and neuropsychiatric diseases.
In 2015, NutriNeuro set up a transfer unit (NutriBrain) to structure research in partnership with industry, thereby promoting innovation and transfer.
_heic.png)
Training researchers in Nutrition and Neuroscience
3 Cifre thesis ), 1 CDD post-PhD realised with Abyss Ingredients.
Mathilde Chataigner
2017-2021
“Impact of supplementation with marine extract on neuroinflammation associated with age-related cognitive decline.”
Camille Mougin
2021-2023
“Optimisation of supplementation with marine extract for disorders associated with age-related cognitive decline.”
Optimyss project
Anaïs Taoufik
2023-2026
"Macro-algae and ageing: prevention of cognitive decline and mechanisms of action."
Anaïs Arrivé
2026-2029
"Impact of marine-based supplementation on cognitive changes and mood disorders in women during periods of hormonal upheaval, with a focus on the menopause and the postpartum period."
LabCom SeaMind
.png){kind=logo}
"SeaMind is great news, because it strengthens, accelerates and secures our long-term collaboration with NutriNeuro. It's a clear recognition of our combined expertise, especially in the cognitive health market, which is growing fast and therefore has great potential. SeaMind will help us to innovate, in particular by targeting those most vulnerable to cognitive disorders. This LabCom is a great source of pride for Abyss."
Alexis Mehaignerie - CEO, Abyss Ingredients
The stakeholders
.jpeg)
.webp)
